AMBAGON THERAPEUTICS
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor-suppressing protein. AmbAgon Therapeutics was founded by Christian Ottmann, Lucas Brunsveld, and Michelle Arkin.
AMBAGON THERAPEUTICS
Industry:
Biotechnology Medical Product Research
Founded:
2020-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ambagontx.com
Total Employee:
11+
Status:
Active
Contact:
650-231-5131
Total Funding:
148 M USD
Technology used in webpage:
Google Maps Google Google Cloud
Similar Organizations
AnHeart Therapeutics
AnHeart Therapeutics is a developer of innovative pharmaceutical products.
Aristea Therapeutics
Aristea Therapeutics is a developer of novel therapies created for autoimmune diseases.
Atomo Coffee
Atomo Coffee is a developer of molecular coffee.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Mission BioCapital
Mission BioCapital investment in Series A - AmbAgon Therapeutics
RA Capital Management
RA Capital Management investment in Series A - AmbAgon Therapeutics
Surveyor Capital
Surveyor Capital investment in Series A - AmbAgon Therapeutics
MRL Ventures Fund
MRL Ventures Fund investment in Series A - AmbAgon Therapeutics
Inkef
Inkef investment in Series A - AmbAgon Therapeutics
Droia Ventures
Droia Ventures investment in Series A - AmbAgon Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - AmbAgon Therapeutics
Nextech Invest
Nextech Invest investment in Series A - AmbAgon Therapeutics
Official Site Inspections
http://www.ambagontx.com Semrush global rank: 4.71 M Semrush visits lastest month: 1.96 K
- Host name: 3.121.247.35.bc.googleusercontent.com
- IP address: 35.247.121.3
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AmbAgon Therapeutics"
About - Ambagon Therapeutics
Steve Davidsen, Ph.D., is Vice President, Oncology Discovery in AbbVie’s R&D organization, …See details»
AmbAgon Therapeutics - Crunchbase Company Profile …
AmbAgon Therapeutics is a developer of cancer molecule therapeutics. The company offers research of a small molecule that augments a tumor …See details»
Ambagon Therapeutics Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ambagon …See details»
Our Science - Ambagon Therapeutics
Aug 7, 2020 How 14-3-3 Works. 14-3-3 proteins interact with their clients in a specific binding …See details»
Ambagon Therapeutics - LinkedIn
Ambagon Therapeutics | 4,551 followers on LinkedIn. Expanding the druggable proteome to drug intrinsically disordered proteins. | Ambagon is discovering and developing small molecule cancer drugs ...See details»
Ambagon Therapeutics Company Profile 2024: Valuation, Funding ...
Ambagon Therapeutics General Information Description. Developer of small-molecule cancer …See details»
Ambagon Therapeutics - Craft
Ambagon Therapeutics has 5 employees across 2 locations and $92.2 m in total funding,. See …See details»
Ambagon Therapeutics: Contact Details and Business Profile
Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct …See details»
Ambagon Therapeutics Company Overview, Contact Details
[email protected]: [email protected]: 1%. [email protected]: …See details»
Ambagon Therapeutics - Overview, News & Similar companies
Jan 6, 2022 Ambagon Therapeutics wordt gelanceerd met $ 85 miljoen Serie A om …See details»
Contact - Ambagon Therapeutics
NETHERLANDS Catalyst Business Center De Lismortel 31 5612 AR Eindhoven. VAT: …See details»
Ambagon Therapeutics - Lifesciences @ Work
AmbAgon develops first-in-class small-molecule therapeutics for breast cancer by augmenting …See details»
Ambagon Therapeutics on LinkedIn: Ambagon Therapeutics • The …
We are the 14-3-3 molecular glue company dedicated to expanding the druggable proteome by …See details»
AmbAgon Therapeutics - Work in biotech
Ambagon Therapeutics is enhancing the activity of tumor suppressors by creating cancer …See details»
Platform & Pipeline - Ambagon Therapeutics
Our pipeline currently focuses on oncology, where multiple opportunities exist to engage …See details»
Ambagon Therapeutics on LinkedIn: About • Ambagon Therapeutics
This month we had the pleasure of welcoming Vicky Lin as Sr. Principal Scientist to our Cell …See details»
Ambagon Therapeutics | Insights
Already A Biomedtracker Subscriber? You have access to the full company record through …See details»
Join Us - Ambagon Therapeutics
Join our team today. Ambagon was inspired by the world-class research in the laboratories of …See details»
Ambagon Therapeutics Email Format | ambagontx.com Emails
Ambagontx.com; 1 510220XXXX; Jinxia Deng Senior Director, Computational Chemistry at …See details»